Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 29, 2018
Dec. 30, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 46,730 $ 31,558 $ 23,304
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 39,714 19,190 11,318
Loss on disposal of assets 56 1,539 329
Stock-based compensation expense 4,271 4,042 4,848
Amortization of debt issuance costs 729 334 47
(Benefit) provision for deferred income taxes (1,455) (6,791) 77
Amortization of acquisition-related inventory step-up 4,441 1,774 1,021
Change in fair value of contingent consideration 1,482 9,476 0
Non-cash restructuring and related charges   390  
Forward contract losses, net 3,496    
Other, net (86) 318 179
(Increase) decrease in, net of acquisitions:      
Accounts receivable (5,976) (11,063) (3,158)
Inventories (11,703) (13,063) (1,380)
Income taxes receivable (4,054) 512 (1,628)
Other current assets 565 254 (153)
Other assets (1,299) (820) (106)
Increase (decrease) in, net of acquisitions:      
Accounts payable 5,894 5,780 2,566
Accrued expenses and other liabilities (1,400) 1,497 656
Income taxes payable (5,031) 3,404 838
Other noncurrent liabilities 1,076 1,051 (252)
Net cash provided by operating activities 77,450 49,382 38,506
Cash flows from investing activities:      
Acquisitions of businesses, net of cash acquired (534,662) (500) (200,056)
Investment in licensed technology     (1,227)
Capital expenditures (28,380) (22,205) (6,187)
Proceeds from dispositions of equipment 62 47 7
Purchases of short-term investments     (24,699)
Proceeds from sale of short-term investments   6,684 62,374
Cash settlement of forward contract (2,535)    
Net cash used in investing activities (565,515) (15,974) (169,788)
Cash flows from financing activities:      
Borrowings on revolving credit facility 282,500   140,000
Repayment of borrowings on revolving credit facility (142,750) (24,000)  
Borrowings on long-term non-revolving debt 101,447    
Repayment of borrowings on long-term non-revolving debt (3,825)    
Borrowings under factoring arrangements 3,184    
Repayment of borrowings under factoring arrangements (3,120)    
Payments on capital lease obligations (961)    
Stock compensation income tax expense     (113)
Proceeds from stock issued 241,338 1,156 1,039
Dividends to shareholders (11,003) (10,260) (10,744)
Debt issuance costs (1,763)   (1,959)
Payment of employee tax withholding (365)    
Payment of contingent consideration liability (17,342) (16,985)  
Net cash provided by (used in) financing activities 447,340 (50,089) 128,223
Effect of exchange rate changes on cash, cash equivalents and restricted cash 318 6,345 (4,659)
Net decrease in cash, cash equivalents and restricted cash (40,407) (10,336) (7,718)
Cash, cash equivalents and restricted cash, beginning of period 63,922 74,258 81,976
Cash, cash equivalents and restricted cash, end of period 23,515 63,922 74,258
Cash paid:      
Income taxes 20,227 17,470 12,785
Interest 12,783 3,723 364
Supplemental disclosure of noncash transactions:      
Common stock issued for shared distribution through accrued expenses and other liabilities   628 1,679
Unrealized gain on available-for-sale securities   391 871
Unrealized loss on interest rate swap (2,309)    
Contingent consideration incurred in connection with acquisition 938   $ 35,077
Measurement period adjustment to goodwill and contingent consideration   $ 4,504  
Stock issued for acquisition $ 17,339